In 2020.0 ORG LETT published article about NOVO ASYMMETRIC-SYNTHESIS; NEGATIVE BREAST-CANCER; KINASE RSK; INTEGRIN ACTIVATION; INHIBITOR; PHOSPHORYLATION; ALKYLATION; PATHWAY; GENOME in [Wu, Bulan] Univ Guam, Coll Nat & Appl Sci, Div Nat Sci, Mangilao, GU 96923 USA; [Sandusky, Zachary M.; Fukuda, Shinji; Lannigan, Deborah A.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Fukuda, Shinji] Ehime Univ, Proteosci Ctr, Div Cell Growth & Tumor Regulat, Toon, Ehime 7910295, Japan; [Fukuda, Shinji] Ehime Univ, Dept Biochem & Mol Genet, Grad Sch Med, Toon, Ehime 7910295, Japan; [Li, Yu; Vemula, Rajender; Zhang, Qi; Li, Mingzong; O’Doherty, George A.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Lannigan, Deborah A.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA; [Lannigan, Deborah A.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA in 2020.0, Cited 33.0. The Name is 1,1,1-Triethoxyethane. Through research, I have a further understanding and discovery of 78-39-7. Safety of 1,1,1-Triethoxyethane
An asymmetric synthesis of two analogues of SL0101 (1) has been achieved. The effort is aimed at the discovery of inhibitors of the p90 ribosomal S6 kinase (RSK) with improved bioavailability. The route relies upon the use of the Taylor catalyst to regioselectively install C-3 ” acetyl or carbamate functionality. This study led to the identification of a third-generation analogue of SL0101 with a C-4 ” n-Pr-carbamate and a C-3 ” acetate with improved RSK inhibitory activity.
Safety of 1,1,1-Triethoxyethane. Welcome to talk about 78-39-7, If you have any questions, you can contact Li, Y; Sandusky, ZM; Vemula, R; Zhang, Q; Wu, BL; Fukuda, S; Li, MZ; Lannigan, DA; O’Doherty, GA or send Email.
Reference:
Thiazolidine – Wikipedia,
,Thiazolidine – ScienceDirect.com